An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli confers protection in a mouse model of recurrent urinary tract infection.
- DOI
- 10.3389/fimmu.2026.1920497
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1920497,
title = {An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli confers protection in a mouse model of recurrent urinary tract infection.},
author = {Roier S and Devant JM and Hibbing ME and Möbes A and Kruth C and Kovacikova K and Martin SM and Phommaly C and Hannan TJ and Jasny E},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1920497},
url = {https://doi.org/10.3389/fimmu.2026.1920497}
}RIS
TY - JOUR TI - An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli confers protection in a mouse model of recurrent urinary tract infection. AU - Roier S AU - Devant JM AU - Hibbing ME AU - Möbes A AU - Kruth C AU - Kovacikova K AU - Martin SM AU - Phommaly C AU - Hannan TJ AU - Jasny E PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1920497 UR - https://doi.org/10.3389/fimmu.2026.1920497 ER -
APA
S, R., JM, D., ME, H., A, M., C, K., K, K., SM, M., C, P., TJ, H., & E, J. (2026). An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli confers protection in a mouse model of recurrent urinary tract infection.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1920497
Source records
- pubmed · retrieved 2026-09-26T08:43:45.711Z